A detailed history of Aviso Wealth Management transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Aviso Wealth Management holds 10,343 shares of ADCT stock, worth $30,304. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,343
Previous 10,343 -0.0%
Holding current value
$30,304
Previous $32.7 Million 0.32%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.55 - $5.09 $318 - $636
-125 Reduced 1.19%
10,343 $32.7 Million
Q1 2024

May 14, 2024

BUY
$1.66 - $5.29 $17,376 - $55,375
10,468 New
10,468 $47 Million

Others Institutions Holding ADCT

About ADC Therapeutics SA


  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $228M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Aviso Wealth Management Portfolio

Follow Aviso Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aviso Wealth Management with notifications on news.